INTRODUCTION
CoTX1 (cobatoxin 1) is a C-terminal amidated 32-residue toxin with three disulphide bridges that has been isolated from the venom of the Mexican scorpion Centruroides noxius Hoffmann [1] . The toxin belongs to a novel family of scorpion toxins, referred to as α-KTx9 [1, 2] . So far, only two members of this family have been defined, CoTX1 (α-KTx9.1) and CoTX2 (cobatoxin 2; α-KTx9.2). The primary structures of CoTX1 and CoTX2 present less than 45 % sequence identity with other characterized α-KTx members. Since these toxins belong to a new family of scorpion toxins because of their low sequence identities with other K + channel-acting peptides, combined with the increasing number of discovered K + channels, a detailed analysis of CoTX1 may provide a valuable opportunity to further characterize the large array of these ion channel types. At a Abbreviations used: CoTX1, cobatoxin 1; ACoTX1, synthetic structural cobatoxin 1 analogue with Pro and Gln at positions 7 and 9, respectively; NOE, nuclear Overhauser effect; DQF-COSY, double-quantum-filtered correlation spectroscopy; DIANA, distance geometry algorithm for NMR; CNS, crystallography and NMR system; HN, amide proton; Fmoc, N α -(9-fluorenyl)methyloxycarbonyl; SKCa channel, small-conductance Ca 2+ -activated K + channel; IKCa1 channel, intermediate-conductance Ca 2+ -activated K + channel; hIKCa1, human IKCa1; K v channel, mammalian voltage-gated K + channel; Shaker B channel, insect voltage-gated K + channel; Shaker B 44 channel, Shaker B channel formed by α subunits truncated at their N-terminal extremity (region 1-44); TFA, trifluoroacetic acid; MALDI-TOF, matrix-assisted laser-desorption ionization-time-of-flight; 3-D, three-dimensional; r.m.s.d., root mean square deviation. 1 These authors contributed equally to this work. 2 To whom correspondence should be addressed (e-mail sabatier.jm@jean-roche.univ-mrs.fr).
structural level, CoTX1 possesses the consensus motif of scorpion toxins . . . C 1 . . . C 2 XXXC 3 . . . (G/A/S)XC 4 . . . C 5 XC 6 . . . [3] . It is therefore expected to fold according to the standard α/β scaffold of scorpion toxins with a C 1 -C 4 , C 2 -C 5 and C 3 -C 6 disulphide bridge arrangement [1] . At a pharmacological level, CoTX1 reportedly blocks K v (mammalian voltage-gated)-type K + channels [Shaker B (insect voltage-gated) and K v 1.1 K + channels] in the micromolar concentration range. The full characterization of CoTX1 has been hampered by its limited quantities in the venom. A more complete characterization of CoTX1, as well as a detailed examination of its structural properties, requires the successful chemical production of the toxin and its analogues.
In this article we report the solid-phase synthesis of CoTX1 and the determination of its properties: disulphide bridge organization, 3-D (three-dimensional) structure in solution (solved by 1 H-NMR), pharmacology on diverse target channels and computed simulation of toxin docking on K v 1.2 channels. In addition, we designed, chemically synthesized and characterized a CoTX1 analogue, [Pro 7 ,Gln 9 ]-CoTX1, denoted ACoTX1. These two residue substitutions were first selected to restore the RPCQ motif found in Pi1 and to potentially increase peptide binding on apamin-sensitive SKCa channels (small-conductance Ca 2+ -activated K + channels) [4, 5] . The RXCQ motif is indeed present in toxins that potently act on SKCa channels, such as Pi1 [6] , apamin [7] , leiurotoxin 1 [8] , PO5 [9] and Tsk [10] . Second, these mutations were also chosen to affect the CoTX1 dipole moment (electric charge anisotropy) in a way by which it is expected to decrease peptide activity on K v -type K + channels [11] . The experimental data show that, contrary to these expectations, the activity of ACoTX1 is similar to that of CoTX1 for SKCa channels, whereas it is more potent on other K + channel subtypes [IKCa1 channels (intermediate-conductance Ca 2+ -activated K + channels) and several voltage-gated K + channels]. This indicates that the RPCQ motif presents a somehow secondary role regarding peptide binding to SKCa channel, and also suggests that charge anisotropy of CoTX1 does not guide its bioactivity on K + channels.
MATERIALS AND METHODS

Materials
Fmoc [N α -(9-fluorenyl)methyloxycarbonyl]-L-amino acids, Fmoc-amide resin and reagents used for peptide synthesis were obtained from Perkin-Elmer. Solvents were analytical-grade products and purchased from SDS. Enzymes (trypsin and chymotrypsin) were obtained from Roche Molecular Biochemicals.
Chemical synthesis and characterization of CoTX1 and ACoTX1
The CoTX1 and ACoTX1 peptides were obtained by the solidphase technique [12] using a peptide synthesizer (model 433A; Applied Biosystems). Peptide chains were assembled stepwise on 0.25 mmol of Fmoc-amide resin (0.66 mmol of amino group/g) using 1 mmol of Fmoc-amino acid derivatives. The side-chainprotecting groups used for trifunctional residues were: trityl for Cys, Asn and Gln; t-butyl for Ser, Tyr, Thr and Asp; pentamethylchroman for Arg; and t-butyloxycarbonyl for Lys. The Fmoc-amino acid derivatives were coupled (20 min) as their hydroxybenzotriazole active esters in N-methylpyrrolidone (4-fold excess). The peptide resins (≈ 2 g) were each treated for 3 h at 25
• C with a mixture of TFA (trifluoroacetic acid)/water/ thioanisole/ethanedithiol (88:5:5:2, by vol.) in the presence of crystalline phenol (2.2 g). After filtration of the mixtures, the crude peptides were precipitated and washed by adding cold diethyloxide. The crude peptides were pelleted by centrifugation (3000 g; 10 min) and the supernatants were discarded. The reduced CoTX1 and ACoTX1 were then dissolved at 2 mM peptide concentrations in 0.2 M Tris/HCl buffer, pH 8.3, and stirred under air to allow oxidative folding (48 h, 25
• C). The crude folded/oxidized peptides were purified by reversed-phase HPLC (Perkin-Elmer; C 18 Aquapore ODS 20 µm, 250 mm × 10 mm) by means of a 60 min linear gradient of 0-35 % buffer B [0.08 % (v/v) TFA in acetonitrile; where buffer A is 0.1 % (v/v) TFA in water] at a flow rate of 5 ml/min (λ = 230 nm). The homogeneity and identity of synthetic CoTX1 (CoTX1) or ACoTX1 were assessed by (i) analytical C 18 reversed-phase HPLC, (ii) amino acid analysis after acidolysis, (iii) Edman sequencing and (iv) mass determination by MALDI-TOF (matrixassisted laser-desorption ionization-time-of-flight) MS.
Assignment of CoTX1 half-cystine pairings by enzyme-based cleavage of the peptide
CoTX1 (500 µg) was incubated with a mixture of trypsin and chymotrypsin at 10 % (w/w) in 0.2 M Tris/HCl, pH 7.4, for 12 h at 37
• C. The resulting peptide fragments were then purified by reversed-phase HPLC (Vydac C 18 , 5 µm, 4 mm × 150 mm) with a 60 min linear gradient of 0-60 % buffer B at a flow rate of 1 ml/min (λ = 230 nm), and freeze dried prior to their analyses. The CoTX1 fragments were hydrolysed by acidolysis (6 M HCl/ phenol) and their amino acid contents were determined (Beckman; system 6300 amino acid analyser). The peptide fragments were additionally characterized by MS analysis (RP-DE Voyager; Perseptive Biosystems), and Edman sequencing using a gas-phase microsequencer (Applied Biosystems 470A). Under standard HPLC conditions for analysing phenylthiohydantoin amino acid derivatives, diphenylthiohydantoin-cystine elutes at a retention time of 9.8 min.
CD analysis of the CoTX1 peptides
The CD spectra were recorded on a Jasco J-800 dichrograph. A ratio of 2.20 was found between the positive CD band at 290.5 nm and the negative band at 192.5 nm. CD spectra were reported as the absorption coefficient ( ε) per amide. The far-UV CD spectra were acquired at 20
• C in water between 190 and 260 nm using 0.1 cm-pathlength cell. Data were collected twice at 0.5 nm intervals with a scan rate of 50 nm/min. As assessed by amino acid analyses, the concentrations of CoTX1 or ACoTX1 in the samples were 0.1 mg/ml.
3-D structure determination of CoTX1 in solution by 1 H-NMR
NMR spectroscopy
A sample of 0.5 ml of CoTX1 at 5 mM concentration in water/ 2 H 2 O (9:1, v/v) at pH 3.0, uncorrected for isotope effects, was used for recordings of the NMR spectra. Spectral acquisition of all 1 H-NMR data was achieved as described previously [13] [14] [15] . NOESY spectra were acquired using mixing times of 80 and 120 ms. Clean TOCSY was performed with a spin-lock field strength of 8 kHz and spin-lock time of 80 ms. The amide proton exchange experiments were recorded immediately after dissolution of CoTX1 in 2 H 2 O. A series of NOESY spectra with mixing times of 80 ms were recorded at 300 K, the first one for 1 h, followed by spectra of 10 h each. Furthermore, we obtained the NOE (nuclear Overhauser effect) build-up curves by successively recording NOESYs with 50, 150, 200 and 300 ms mixing times in order to check for spin diffusion.
Data processing
Spectra were processed with Bruker's UXNMR software, running on Silicon Graphics Indy R4400 computer. The matrices were transformed to a final size of 2048 points in the acquisition dimension and to 1024 points in the other, except for coupling constant determination for which a 8192 × 1024 matrix was used. The signal was multiplied by a shifted sine bell window in both dimensions prior to a Fourier transformation, then a fifth-order polynomial baseline correction was applied.
Spectral analysis
The identification of amino acid spin systems and the sequential assignment were achieved using the standard strategy described by Wüthrich [16] , applied with the graphics software XEASY [17] .
Experimental restraints
The integration of NOE data was achieved by measuring the peak volumes. On the basis of known distances in regular secondary structures (d Hα-Hα = 0.23 nm and d HN-HN = 0.33 nm between two strands of an anti-parallel β-sheet; where HN is amide proton), these volumes were translated into upper limit distances by the CALIBA (calibration of NOE intensity versus distance bonds) routine [18] of DIANA (distance geometry algorithm for NMR) [19] software. All parameters used in the calculations were identical to those used in [20] . The value of the 3 J HN-Hα coupling constant was obtained from the first local minimum. The 3 J HN-Hα coupling constants were translated into angle restraints using HABAS from the DIANA [19] .
Structure calculations
Distance geometry calculations were performed with the variable target function program DIANA 2.8. A preliminary set of 1000 structures was initiated including only intraresidual and sequential upper limit distances. From these, the 500 best were selected for a second round, including medium-range distances, and the resulting 250 best for a third one, with the whole set of upper limit restraints, and some additional distance restraints, used to define the disulphide bridges (i.e. d Sγ,Sγ = 0.21 nm, d Cβ,Sγ and d Sγ,Cβ = 0.31 nm). Starting from the 50 best structures, a REDAC (redundant dihedral angle constraints) strategy [19] was used in the last step to include the dihedral restraints together with the additional distance restraints coming out from hydrogen bonds. Final energy refinement was achieved by CNS (crystallography and NMR system; a software suite for macromolecular structure determination) [25] . The visual analysis was carried out with Turbo-Frodo software [21] . The geometric quality of the resulting CoTX1 structures was assessed using PROCHECK 3.3 and PROCHECK-NMR software [22] . The molecular modelling of K v channel subtypes (S5-H5-S6 pore domains) has been achieved on the basis of the crystal structure of part of the KcsA channel solved at 2.0 Å resolution (PDB accession number 1K4C) [23] . The amino acid sequences of domains S5-H5-S6 of the rat voltage-gated K + channel α-subunits [24] were aligned with region 26-125 of KcsA. The sequence identities between the K v -type ion channel regions and KcsA are ≈ 31 %. For the regions comprised between the two transmembrane segments S5 and S6, the sequence identities with KcsA were ≈ 47 %. Based on the high degree of similarity, models of the S5-H5-S6 regions of mouse K v 1.1 (NCBI accession number P16388), rat K v 1.2 (NCBI accession number P15386) and mouse K v 1.3 (NCBI accession number P16390) channels were generated by using the Turbo-Frodo software [21] . After Clustal alignments (http://www.ebi.ac.uk/clustalw), the amino acid residue mutations were introduced in the KcsA channel, and the structures of the corresponding K v channels were minimized by using the CNS software [25] . The final molecular models of the S5-H5-S6 regions of the K v 1.1, K v 1.2 and K v 1.3 channels adopt 3-D structures that are similar to that of the KcsA channel. Of note, the ion channel pore region is formed by four S5-H5-S6 domains.
To create a molecular model of ACoTX1, amino acid residue mutations were performed within the amino acid sequence of CoTX1 (PDB accession number 1PJV). The model of ACoTX1 was found to be closely related to the 3-D structure of CoTX1 in solution. The final minimized molecular model of ACoTX1 showed an α/β scaffold, as found in most scorpion toxins [3] .
Electrostatic calculations
The electrostatic calculations together with the dipole moments and related analysis were performed by using the GRASP software [26] running on Silicon Graphics Workstations. The potential maps were calculated with a simplified Poisson-Boltzmann solver [27] on the basis of an AMBER-derived parameter file.
Docking of CoTX1 peptides on to K v 1.2 channel
The molecular interaction simulations were performed using the BiGGER docking program [28] . The algorithm used by BiGGER performs a complete and systematic search for surface complementarity (both geometry complementarity and amino acid residue pairwise affinities are considered) between two potentially interacting molecules, and enables an implicit treatment of molecular flexibility. In each case, a population of 1000 candidate protein-protein-docked geometries were selected by BiGGER. In a subsequent step, the putative docked structures were ranked using an interaction scoring function, which combines several interaction terms that are thought to be relevant for the stabilization of protein complexes: geometric packing of the surfaces, electrostatic interactions, desolvation energy and pairwise propensities of the amino acid residue side chains to contact across the molecular interface. In the ab initio simulations, the entire molecular surface was searched without any additional information regarding the binding sites. Among the 1000 candidate protein-protein-docked geometries selected, the five best scoring CoTX1-K v 1.2 or ACoTX1-K v 1.2 channel complexes were further treated with the Turbo-Frodo software, also taking into account the deduced functional maps of voltage-gated K + channel-acting scorpion toxins (for review see [29] ). Finally, a rigid-body minimization was used to minimize the selected complexes. The best energy solutions, corresponding to the most favourable CoTX-K v 1.2 and ACoTX-K v 1.2 channel complexes were retained. The de visu analysis was done using Turbo-Frodo software, and the geometric quality of the structures was assessed by PROCHECK 3.3 [22] .
Neurotoxicity of CoTX1 peptides in vivo
The peptides were tested in vivo for toxicity by determining the 50 % lethal dose (LD 50 ) after intracerebroventricular injections into 20 g C57/BL6 mice (animal testing agreement number 006573, delivered by the Ministère de l'Agriculture et de la Pêche, France). Groups of six mice per dose were injected with 5 µl of CoTX1 or ACoTX1 peptide solution containing 0.1 % (w/v) BSA and 0.9 % (w/v) NaCl.
Inhibition of 125 I-apamin binding on to SKCa channels from rat brain synaptosomes by CoTX1 peptides
Rat brain synaptosomes were prepared as described previously [30] . Aliquots of 50 µl of 0.1 nM 125 I-apamin were added to 400 µl of synaptosome suspension (0.4 mg of protein/ml). [1] , charybdotoxin (ChTX [38] ), noxiustoxin (NTX [39] ), kaliotoxin (KTX [40] ), TsTx-α [41] , leiurotoxin 1 (LTX [8] ), Pi1 [4] , Pi2 [42] and P01 [43] were aligned according to the positions of their half-cystine residues, except for Pi1 which belongs to the particular α-KTx6 family of four-disulphide-bridged scorpion toxins acting on K + channels. The nine scorpion toxin structural families are noted; α-KTx1-9 [1, 2] . Gaps (−) were introduced into the toxin amino acid sequences to maximize homology. The positions of half-cystine residues are highlighted in grey boxes. The asterisk indicates a C-terminal carboxylamidated extremity. Amino acid sequence identities (%) with CoTX1 are shown on the right. (B) Amino acid sequences of CoTX1 and its analogue, ACoTX1. The grey box illustrates the four-residue motif that is thought to be important for SKCa channel recognition.
centrifuged and the resulting pellets were washed three times in 1 ml of the same buffer. Bound radioactivity was determined by gamma counting (Packard Crystal II). The values expressed are the means + − S.D. from triplicate experiments. Non-specific binding, less than 10 % of the total binding, was determined in the presence of an excess (10 nM) of unlabelled apamin. 
Electrophysiological recordings
All the experiments were carried out at room temperature (22) (23) (24) (25) • C) using the whole-cell recording mode of the patch-clamp technique [32, 33] . Cells were bathed with mammalian Ringer's solution containing 160 mM NaCl, 4.5 mM KCl, 2 mM CaCl 2 , 1 mM MgCl 2 and 10 mM Hepes, pH 7.4 (with NaOH), with an osmolarity of 290-320 mOsm. When CoTX1 peptides were applied, 0.1 % BSA was added to the Ringer's solution. A simple syringe-driven perfusion system was used to exchange the bath solution in the recording chamber. Electrodes were pulled from glass capillaries (Science Products, Hofheim, Germany) in three stages, and fire-polished to resistances measured in the bath of 2.5-5 M . The internal pipette solution used for measuring voltage-gated K + currents contained 155 mM KF, 2 mM MgCl 2 , 10 mM Hepes and 10 mM EGTA, pH 7.2 (with KOH), with an osmolarity of 290-320 mOsm. For measuring K + currents through IKCa1 channels, an internal pipette solution containing 135 mM potassium aspartate, 8.7 mM CaCl 2 , 2 mM MgCl 2 , 10 mM EGTA and 10 mM Hepes, pH 7.2 (with KOH), with an osmolarity of 290-320 mOsm (free [Ca 2+ ] i = 10 −6 M), was used. Membrane currents were measured with an EPC-9 patch-clamp amplifier (HEKA Elektronik, Lambrecht, Germany) interfaced to a Macintosh computer running acquisition and analysis software (Pulse and PulseFit). Capacitive and leak currents were subtracted using the P/10 procedure of this software. Series resistance compensation (> 80 %) was employed if the current exceeded 2 nA. The holding potential in all experiments was − 80 mV. Data analysis was performed in IgorPro, and K d values were deduced by fitting a modified Hill equation
with a Hill coefficient of 1, to normalized data points obtained at more than four different CoTX1 peptide concentrations. The value for each peptide concentration was the mean from at least three measurements.
RESULTS AND DISCUSSION
CoTX1, a member of a new family of scorpion toxins
CoTX1 belongs to a new family of α-KTx scorpion toxins (α-KTx9) [1, 2] . As shown in Figure 1 type. Such a scaffold consists of a helical structure connected to an anti-parallel β-sheet by two disulphide bridges. CoTX1 has a shorter N-terminal domain than toxin members of the α-KTx1-4 families indicating that it possesses a two-rather than a three-stranded β-sheet. The primary structures of both CoTX1 and its analogue ACoTX1 are presented in Figure 1(B) . The two residue substitutions made in CoTX1 amino acid sequence are located in a domain that presumably forms a helical structure [1] .
Chemical syntheses and characterizations of CoTX1 and its analogue ACoTX1
Solid-phase chemical syntheses of CoTX1 and ACoTX1 were achieved stepwise on 0.25 mmol of Fmoc-amide resin by means of an Fmoc/t-butyl strategy [12] . In both cases, the amount of target peptide linked to the resin was ≈ 0. 
Disulphide bridge pattern of CoTX1
To assign CoTX1 half-cystine pairings, the peptide was treated by a mixture of trypsin and chymotrypsin, and the resulting fragments were purified by HPLC and characterized by amino acid content determination, Edman sequencing and MS analysis ( Figure 2B ). The half-cystine pairings were thereby mapped as Cys 3 -Cys 22 , Cys 8 -Cys 27 and Cys 12 -Cys 29 . The disulphide bridge organization of CoTX1 is therefore of the C 1 -C 4 , C 2 -C 5 and C 3 -C 6 type, a pattern commonly found in three-disulphide-bridged scorpion toxins [29] .
CD analysis
The CD spectra of CoTX1 and ACoTX1 were recorded to assess their secondary structures (results not shown). Measurements were performed at a wavelength ranging from 185 to 260 nm. The data obtained correspond essentially to π-π * and n-π * transitions of the amide chromophores of the peptide backbones [34] . The CD spectra show large negative contributions between 207 and 230 nm, and large positive contributions between 190 and 200 nm, indicating the presence of both α-helical and β-sheet structures. These data are coherent with peptide backbone folding according to an α/β scaffold [3] for both CoTX1 and ACoTX1. [16] , and second, most protons were identified and the resonance frequencies determined ( Table 1 ). The structures of CoTX1 were determined by using 348 NOE-based distance restraints (135 intra-residue, 82 sequential, 52 medium-range and 79 long-range restraints). In addition, 28 hydrogen-bond restraints (derived from hydrogen-exchange data) have been included, as well as nine distance restraints derived from the three disulphide bridges. Altogether, the final experimental set corresponds to 12 constraints per residue on average (Figure 4A) . The structures were calculated by using a hybrid distance geometry-simulated annealing protocol using distance geometry algorithm for NMR (DIANA [19] ) and CNS [25] . The best-fit superimposition of backbone atoms for 20 models gives r.m.s.d. (root mean square deviation) values of 0.52 Å for backbone atoms and 1.14 Å if all known hydrogen atoms are included ( Figure 4B ; Table 2 ). The local r.m.s.d. values are represented on Figure 4 (B) and show that the precision of the calculation is quite constant all along the CoTX1 amino acid sequence. A summary of the structural statistics is given in Table 2 . All the 20 CoTX1 solution structures ( Figure 4C ) have good non-bonded contacts and covalent geometry, as evidenced by low values of CNS energy terms. The correlation with the experimental data shows no NOE-derived distance violation greater than 0.2 Å. Also, the analysis of the Ramachandran plot shows (according to PROCHECK standard nomenclature) 83 % of the residues in the most favoured regions, 17 % in the additional favoured regions and none in the generously allowed or disallowed regions. The 3-D structures (PDB accession code 1PJV) of CoTX1 consist of an homogeneous family, sharing the same fold: a two-stranded β-sheet and an α-helix ( Figure 4D ). The precise localization of these secondary structures has been defined by PROCHECK-NMR, which indicates the presence of a α-helix running from Tyr 5 to Arg 14 (two turns of helix), and a double-stranded antiparallel β-sheet made of the Arg 18 -Ile 23 and Ala 26 -Tyr 30 portions. This β-sheet is right-hand twisted and stabilized by six hydrogen bonds. The α-helix is connected to the β-sheet by a tight turn formed by the region Arg 15 -Tyr 17 . The two strands of the β-sheet are connected by a well-defined type I β-turn formed by the Asn 24 and Asn 25 residues ( Figure 4D ). Of note, the angle between the axis of the α-helix and that of the β-sheet is close to 0
• . These secondary structures fully agree with the experimental data presented in Figure 3 (B) and Figure 4 (A). The current 3-D solution structure determination of CoTX1 concerns the synthetic molecule. It most probably also reflects the 3-D structure of the native CoTX1 that could not be determined due to its current unavailability. However, several points argue in favour of their full identity. First, the 3-D solution structure of synthetic CoTX1 is remarkably similar to the molecular model previously generated by Selisko and co-workers [1] . Second, the oxidative folding process in vitro of reduced synthetic CoTX1 resembles those of other K + channel-acting toxins of known 3-D structures [6,9,10]. Functional maps depicting amino acid residues that are key for toxin interaction with K v -type channels (top row, β-sheet side), hydrophobic surfaces (middle row, β-sheet side) and ribbon representations (bottom row) of CoTX1 and other K v channel-acting toxins representative (9, 1-4, 6 and 7) of the α-KTx family. The dipole moments of representative toxins (red) are compared with that of CoTX1 (green). Colour codes used for the amino acid residues are as in Figure 5 (A). Note that amino acid residues belonging to the basic ring of CoTX1 are omitted for the sake of comparison with other toxins. MTX, maurotoxin (a scorpion toxin from Scorpio maurus palmatus venom); AgTX2, agitoxin 2 (a scorpion toxin from Leiurus quinquestriatus hebraeus); other toxin names are defined in Figure 1 .
Third, the half-cystine pairing pattern experimentally determined for folded/oxidized synthetic CoTX1 is identical to those of other three-disulphide-bridged scorpion toxins acting on K + channels (i.e. C 1 -C 4 , C 2 -C 5 and C 3 -C 6 ), strongly suggesting the occurrence of a correct folding in vitro. Finally, we also evidenced an α/β-scaffold for synthetic CoTX1, consistent with all known 3-D solution structures of related toxins.
Surface analysis of CoTX1
The surface of CoTX1 is predominantly composed of polar and hydrophilic amino acid residues. Indeed, all four Lys, four Arg, two Asn and two Asp residues are exposed to the solvent (Figure 5A ). All the polar residues are in contact with the solvent, although no well-defined salt bridges can be detected at the CoTX1 surface. In the complete bundle of NMR solutions, most of the exposed residue-side-chains are mobile (Figures 4B and 4C) . A number of hydrophobic residues (Ala 1 , Val 2 , Val 4 and Ile 23 ) form a solvent-exposed hydrophobic cluster on one side of the molecule. Another hydrophobic cluster, located at the opposite side of CoTX1, is composed of Tyr 17 , Tyr 30 and Tyr 32 , packed against Pro 31 .
The dipole moment of CoTX1 resulting from its chargedistribution anisotropy is shown by an arrow on Figure 5 (B). It is directed from the centre of the molecule and oriented from the lowest to the highest positive charge density. The size of the arrow is proportional to the intensity of the anisotropy. It emerges from the molecule through a basic-rich surface (Arg 6 , Lys 10 , Lys 13 , Arg 14 and Lys 21 ; only one acidic Asp 8 residue); the opposite face being poorly basic (Arg 15 and Lys 28 ; and one acidic Asp 9 residue).
Structural comparison between CoTX1 and toxins from other α-KTx families
The comparison of the 3-D structure of CoTX1 with those of other structurally well-characterized toxins from the diverse families highlights the conservation of five specific amino acid residues (Lys 21 , Ile 23 , Asn 24 , Lys 28 and Tyr 30 ) reportedly critical for voltage-gated K + channel blockage ( Figure 6 , top row; for a review see [29] ). This observation is in line with the ability of CoTX1 to block Shaker B and K v 1.1 channels [1] . One striking difference carried by CoTX1 over other toxins is the presence of two hydrophobic residue clusters located at either side of its functional dyad (Lys 21 and Tyr 30 ; Figure 6 , middle row). This property, combined with a longer α-helix, makes CoTX1 less globular than other characterized toxins. It is noteworthy that some hydrophobic clusters can also be found in other toxins, although they are generally not distributed in such a diametrically opposite manner. An analysis of the dipole moment of CoTX1 reveals that it exhibits a charge anisotropy similar to those of toxins active on both K v and SKCa K + channels ( Figure 6 , bottom row). Apart from the toxin functional maps, it has also been proposed that the peptide dipole moments could be pivotal for K + channel recognition and blockage [11] . To investigate this point, we designed and chemically synthesized a structural analogue of CoTX1, termed ACoTX1, with the aim of decreasing the intensity but not the orientation of the dipole moment. ACoTX1 presents two amino acid residue substitutions as compared with CoTX1, i.e. Pro 7 and Gln 9 instead of Thr 7 and Asp 9 . The residue mutation from Asp 9 to Gln 9 affects the intensity of the dipole moment by altering an amino acid residue that is located at the centre of the face opposite to the β-sheet interacting surface. In addition, Thr 7 was replaced by Pro 7 to eliminate the potential contribution of the hydroxyl side-chain of Thr to the dipole moment. A Pro residue was selected because (i) of its neutral nature regarding the dipole moment and (ii) it restores the RPCQ motif found in Pi1, a toxin that potently acts on SKCa channels [6] .
Modelled structure of ACoTX1
To generate a molecular model of ACoTX1, residue replacements were performed within the 3-D structure of CoTX1 using the Turbo-Frodo software [21] . The structure of ACoTX1 was refined by molecular annealing dynamics, followed by energy minimization using the CNS software. Figure 5 (C) illustrates that the refined molecular model of ACoTX1 has a similar distribution of toxin key residues for K v channel blockage. Also, the distribution of the two clusters of hydrophobic residues are maintained within ACoTX1 ( Figure 5D ). However, the molecular dipole moment presents the same orientation as that of CoTX1, but is markedly decreased in intensity ( Figure 5E ). This situation appears to be convenient to address the relative importance of the dipole moment in toxin bioactivity.
Bioactivities of CoTX1 and ACoTX1
CoTX1 and ACoTX1 were tested in vivo for neurotoxicity by intracerebroventricular injections in C57/BL6 mice. Both peptides are lethal in mice, with LD 50 values of 500 + − 45 ng/mouse (CoTX1, n = 48 mice) and 300 + − 32 ng/mouse (ACoTX1, n = 48 mice). This lethal activity is 10-20-fold less potent than other known three-disulphide-bridged scorpion toxins [9, 10] . Of note, ACoTX1 displays an increased lethal activity compared with its natural counterpart.
To investigate the pharmacological actions of CoTX1 and ACoTX1, we first tested their abilities to compete with 125 I-apamin for binding on to SKCa channels of rat brain synaptosomes (Figure 7A ). Both peptides inhibit 125 I-apamin binding with IC 50 values of 7.2 + − 0.2 µM (CoTX1) and 4.8 + − 0.2 µM (ACoTX1). The affinity of these two peptides for SKCa channels thus appears weak. Next, we evaluated the effects of CoTX1 and ACoTX1 on hIKCa1 expressed in the tsA cell line [35, 36] (Figure 7B ). Both peptides fully inhibit hIKCa1 K + currents with IC 50 values of 484 + − 62 nM (CoTX1) and 73 + − 7 nM (ACoTX1). ACoTX1 is thus 6.5-fold more active than CoTX1 for interacting with hIKCa1. These data are the first evaluating CoTX1 activity towards Ca 2+ -activated K + channels. We also tested the effects of both peptides on voltage-gated K + channels expressed in mammalian cell lines (Figure 8 ). Dose-response curves were obtained for rat K v 1. Both peptides were also evaluated on human K v 1.5 and mouse K v 3.1 channels and were found to be inactive at concentrations in the micromolar range. Two points should be noted from the pharmacological data. First, ACoTX1 was designed to introduce the RXCQ motif in CoTX1, which supposedly should improve its affinity for SKCa channels. This was not the case, suggesting that the motif is not sufficient per se to improve the affinity of the peptide for SKCa channels. Second, the two mutations introduced in ACoTX1 were chosen to affect the CoTX1 dipole moment in a way that should have decreased its activity on K v -type K + channels [11] . The opposite result was obtained, suggesting that charge anisotropy of CoTX1 is unlikely to be key for its bioactivity on K + channels.
Docking of CoTX1 on to rat K v 1.2 channel
To examine the interaction between CoTX1 and rK v 1.2 at the molecular level, we generated a model of K v 1.2 to allow a docking simulation of CoTX1 on this channel. K v 1.2 was selected for docking simulations over other K + channels because of its highaffinity interaction with CoTX1.
We first performed a Blastp (version 2.2.5; http://us.expasy.org/ tools/blast/) search against the whole Protein Data Bank, to select the correct template to generate a model of the rK v 1.2 channel (S5-H5-S6 region). The KcsA [23] and KvAP [37] primary structures (Swiss-Prot codes 1BL8 and 1ORS) showed the best E-Value scores for rK v 1.2. Similar models of K v 1.2 were obtained using either KcsA or KvAP as a template. In the following description of the results, we exclusively report data generated with KcsA as template. The 3-D structure of CoTX1 in solution, described herein, and the molecular model of ACoTX1, were used in docking experiments with the rK v 1.2 model (S5-H5-S6 region) generated according to the procedures described in the Materials and methods section. Figure 9 illustrates residues. The Lys 21 (dyad) side chain of CoTX1 would enter the ion channel pore to block K + efflux. Similar docking analyses based on models of K v 1.1 and K v 1.3 did not give good scores for CoTX1, in agreement with its poor bioactivity on these channels. In contrast, results from the docking simulation of the ACoTX1 model on K v 1.2 reveal an identical positioning of the peptide over the channel. It should be noted that in the ACoTX1 primary structure, the two residue substitutions (Pro 7 and Gln 9 ), as compared with its native counterpart, are located close to two out of the five potentially important residues of the basic ring (Arg 6 and Lys 10 ). The presence of a negative charge on the side chain of Asp 9 in CoTX1 may weaken the interaction between Lys 10 of CoTX1 and Asp 355 of Kv1.2. The substitution of Asp 9 by an uncharged Gln residue in ACoTX1 may, on the contrary, reinforce this interaction. Such an alteration in electrostatic properties could provide a reasonable explanation regarding the increased affinity of ACoTX1 for K v -type channels.
Concluding remarks
In the present work, we describe for the first time the chemical synthesis, disulphide bridge organization, 3-D solution structure and docking results of CoTX1, a member of a novel class of α-KTx toxins. CoTX1, which is folded according to a α/β-scaffold, is the first toxin cross-linked by three disulphide bridges that is shown to be active on both voltage-gated (K v 1.2) and calcium-activated (IKCa1) K + channels. Our work extends a previous study made by Selisko and co-workers in defining the pharmacological targets of CoTX1 [1] . It was shown by these authors that CoTX1 inhibits Shaker B and mouse Kv1.1 channels. It will be of interest to evaluate the effects of CoTX1 on a still wider range of potential pharmacological targets in future experiments, including channels with different ionic selectivity.
With regard to the current targets, it is clear that docking experiments will be helpful to guide the design of more potent and/or selective CoTX1 structural analogues. In this respect, ACoTX1 already appears to be a higher-affinity blocker for several K + channels tested here (K v 1.2, K v 1.3, Shaker B 44 and IKCa1). From the use of this analogue, we conclude that charge anisotropy does not appear to be a relevant factor in ion-channel recognition and blockage. Further experimental data will be required to evaluate whether the dipole moments of other scorpion toxins have a role in the properties of these toxins.
We thank P. Mansuelle for his help in this work. We acknowledge financial support from the CNRS and Cellpep S. A.
